Works by Hiddemann, Wolfgang

Results: 165
    1
    2
    3
    4
    5
    6

    Antikörpertherapie maligner Lymphome.

    Published in:
    Medizinische Klinik (Urban & Vogel), 2005, v. 100, n. 1, p. 14, doi. 10.1007/s00063-005-1115-0
    By:
    • Buske, Christian;
    • Dreyling, Martin;
    • Unterhalt, Michael;
    • Hiddemann, Wolfgang
    Publication type:
    Article
    7
    8

    Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial.

    Published in:
    Clinical & Translational Immunology, 2020, v. 9, n. 3, p. 1, doi. 10.1002/cti2.1117
    By:
    • Lichtenegger, Felix S;
    • Schnorfeil, Frauke M;
    • Rothe, Maurine;
    • Deiser, Katrin;
    • Altmann, Torben;
    • Bücklein, Veit L;
    • Köhnke, Thomas;
    • Augsberger, Christian;
    • Konstandin, Nikola P;
    • Spiekermann, Karsten;
    • Moosmann, Andreas;
    • Boehm, Stephan;
    • Boxberg, Melanie;
    • Heemskerk, Mirjam HM;
    • Goerlich, Dennis;
    • Wittmann, Georg;
    • Wagner, Beate;
    • Hiddemann, Wolfgang;
    • Schendel, Dolores J;
    • Kvalheim, Gunnar
    Publication type:
    Article
    9

    Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia.

    Published in:
    Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-29593-2
    By:
    • Hornung, Roman;
    • Jurinovic, Vindi;
    • Batcha, Aarif M. N.;
    • Bamopoulos, Stefanos A.;
    • Rothenberg-Thurley, Maja;
    • Amler, Susanne;
    • Sauerland, Maria Cristina;
    • Berdel, Wolfgang E.;
    • Wörmann, Bernhard J.;
    • Bohlander, Stefan K.;
    • Braess, Jan;
    • Hiddemann, Wolfgang;
    • Lehmann, Sören;
    • Mareschal, Sylvain;
    • Spiekermann, Karsten;
    • Metzeler, Klaus H.;
    • Herold, Tobias;
    • Boulesteix, Anne-Laure
    Publication type:
    Article
    10

    Current Management of Mantle Cell Lymphoma.

    Published in:
    Drugs, 2007, v. 67, n. 12, p. 1689, doi. 10.2165/00003495-200767120-00004
    By:
    • Weigert, Oliver;
    • Unterhalt, Michael;
    • Hiddemann, Wolfgang;
    • Dreyling, Martin
    Publication type:
    Article
    11

    Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model.

    Published in:
    Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01553-6
    By:
    • Archer, Kellie J.;
    • Fu, Han;
    • Mrózek, Krzysztof;
    • Nicolet, Deedra;
    • Mims, Alice S.;
    • Uy, Geoffrey L.;
    • Stock, Wendy;
    • Byrd, John C.;
    • Hiddemann, Wolfgang;
    • Braess, Jan;
    • Spiekermann, Karsten;
    • Metzeler, Klaus H.;
    • Herold, Tobias;
    • Eisfeld, Ann-Kathrin
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: A detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.

    Published in:
    Genes, Chromosomes & Cancer, 2002, v. 35, n. 1, p. 20, doi. 10.1002/gcc.10088
    By:
    • Schoch, Claudia;
    • Haferlach, Torsten;
    • Bursch, Sabina;
    • Gerstner, Daniela;
    • Schnittger, Susanne;
    • Dugas, Martin;
    • Kern, Wolfgang;
    • Löffler, Helmut;
    • Hiddemann, Wolfgang
    Publication type:
    Article
    21

    RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.

    Published in:
    Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1505, doi. 10.1007/s00262-015-1755-8
    By:
    • Lichtenegger, Felix;
    • Kondla, Isabell;
    • Krempasky, Michael;
    • Weber, Anna;
    • Herold, Tobias;
    • Krupka, Christina;
    • Spiekermann, Karsten;
    • Schneider, Stephanie;
    • Büchner, Thomas;
    • Berdel, Wolfgang;
    • Wörmann, Bernhard;
    • Hiddemann, Wolfgang;
    • Subklewe, Marion
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28

    An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging.

    Published in:
    PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120925
    By:
    • Vick, Binje;
    • Rothenberg, Maja;
    • Sandhöfer, Nadine;
    • Carlet, Michela;
    • Finkenzeller, Cornelia;
    • Krupka, Christina;
    • Grunert, Michaela;
    • Trumpp, Andreas;
    • Corbacioglu, Selim;
    • Ebinger, Martin;
    • André, Maya C.;
    • Hiddemann, Wolfgang;
    • Schneider, Stephanie;
    • Subklewe, Marion;
    • Metzeler, Klaus H.;
    • Spiekermann, Karsten;
    • Jeremias, Irmela
    Publication type:
    Article
    29

    The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML.

    Published in:
    PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109759
    By:
    • Pastore, Friederike;
    • Greif, Philipp A.;
    • Schneider, Stephanie;
    • Ksienzyk, Bianka;
    • Mellert, Gudrun;
    • Zellmeier, Evelyn;
    • Braess, Jan;
    • Sauerland, Cristina M.;
    • Heinecke, Achim;
    • Krug, Utz;
    • Berdel, Wolfgang E.;
    • Buechner, Thomas;
    • Woermann, Bernhard;
    • Hiddemann, Wolfgang;
    • Spiekermann, Karsten
    Publication type:
    Article
    30
    31

    Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia.

    Published in:
    PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0089560
    By:
    • Janke, Hanna;
    • Pastore, Friederike;
    • Schumacher, Daniela;
    • Herold, Tobias;
    • Hopfner, Karl-Peter;
    • Schneider, Stephanie;
    • Berdel, Wolfgang E.;
    • Büchner, Thomas;
    • Woermann, Bernhard J.;
    • Subklewe, Marion;
    • Bohlander, Stefan K.;
    • Hiddemann, Wolfgang;
    • Spiekermann, Karsten;
    • Polzer, Harald
    Publication type:
    Article
    32
    33

    Follicular Lymphoma--Diagnosis, Treatment, and Follow-Up.

    Published in:
    Deutsches Ärzteblatt International, 2021, v. 118, n. 18, p. 320, doi. 10.3238/arztebl.m2021.0022
    By:
    • Zoellner, Anna;
    • Herfarth, Klaus;
    • Herold, Michael;
    • Klapper, Wolfram;
    • Skoetz, Nicole;
    • Hiddemann, Wolfgang
    Publication type:
    Article
    34

    Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.

    Published in:
    British Journal of Haematology, 2023, v. 202, n. 6, p. 1165, doi. 10.1111/bjh.18982
    By:
    • Pastore, Friederike;
    • Gittinger, Hanna;
    • Raab, Susanne;
    • Tschuri, Sebastian;
    • Ksienzyk, Bianka;
    • Konstandin, Nikola P.;
    • Schneider, Stephanie;
    • Rothenberg‐Thurley, Maja;
    • Horny, Hans‐Peter;
    • Werner, Martin;
    • Sauerland, Maria C.;
    • Amler, Susanne;
    • Görlich, Dennis;
    • Berdel, Wolfgang E.;
    • Wörmann, Bernhard;
    • Braess, Jan;
    • Hiddemann, Wolfgang;
    • Tischer, Johanna;
    • Herold, Tobias;
    • Metzeler, Klaus H.
    Publication type:
    Article
    35

    Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 7, p. 2373, doi. 10.1007/s00277-024-05689-w
    By:
    • Scheubeck, Gabriel;
    • Hoffmann, Martin;
    • Jurinovic, Vindi;
    • Fischer, Luca;
    • Unterhalt, Michael;
    • Schmidt, Christian;
    • Böck, Hans-Peter;
    • Dührsen, Ulrich;
    • Kaesberger, Joachim;
    • Kremers, Stephan;
    • Lindemann, Hans-Walter;
    • Mantovani, Luisa;
    • Hiddemann, Wolfgang;
    • Hoster, Eva;
    • Dreyling, Martin
    Publication type:
    Article
    36

    The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 10, p. 2791, doi. 10.1007/s00277-023-05385-1
    By:
    • Fischer, Luca;
    • Jiang, Linmiao;
    • Bittenbring, Joerg Thomas;
    • Huebel, Kai;
    • Schmidt, Christian;
    • Duell, Johannes;
    • Metzner, Bernd;
    • Krauter, Juergen;
    • Glass, Bertram;
    • Huettmann, Andreas;
    • Schaefer-Eckart, Kerstin;
    • Silkenstedt, Elisabeth;
    • Klapper, Wolfram;
    • Hiddemann, Wolfgang;
    • Unterhalt, Michael;
    • Dreyling, Martin;
    • Hoster, Eva
    Publication type:
    Article
    37
    38

    Efficacy of Consolidation High-Dose Chemotherapy with Ifosfamide, Carboplatin and Etoposide (HD-ICE) Followed by Autologous Peripheral Blood Stem Cell Rescue in Chemosensitive Patients with Metastatic Soft Tissue Sarcomas.

    Published in:
    Oncology, 2006, v. 71, n. 1/2, p. 32, doi. 10.1159/000100447
    By:
    • Schlemmer, Marcus;
    • Wendtner, Clemens-Martin;
    • Falk, Martin;
    • Abdel-Rahman, Sultan;
    • Licht, Thomas;
    • Baumert, Jens;
    • Straka, Christian;
    • Hentrich, Marcus;
    • Salat, Christoph;
    • Hiddemann, Wolfgang;
    • Issels, Rolf-Dieter
    Publication type:
    Article
    39

    A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials.

    Published in:
    EJHaem, 2023, v. 4, n. 4, p. 1042, doi. 10.1002/jha2.796
    By:
    • Kostakoglu, Lale;
    • Martelli, Maurizio;
    • Sehn, Laurie H.;
    • Davies, Andrew;
    • Trněný, Marek;
    • Herold, Michael;
    • Vitolo, Umberto;
    • Hiddemann, Wolfgang;
    • Trotman, Judith;
    • Knapp, Andrea;
    • Mattiello, Federico;
    • Nielsen, Tina G.;
    • Sahin, Deniz;
    • Sellam, Gila;
    • Ward, Carol;
    • Younes, Anas
    Publication type:
    Article
    40
    41
    42
    43
    44
    45

    Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomasThe authors dedicate this paper to Reza Parwaresch, who served as a reference pathologist for the German Low‐Grade Lymphoma Study Group (GLSG) over many years and who died unexpectedly in November 2005.: Results of a prospective randomized trial of the German Low‐Grade Lymphoma Study Group

    Published in:
    Cancer (0008543X), 2006, v. 107, n. 5, p. 1014
    By:
    • Christina Nickenig;
    • Martin Dreyling;
    • Eva Hoster;
    • Michael Pfreundschuh;
    • Lorenz Trumper;
    • Marcel Reiser;
    • Hannes Wandt;
    • Eva Lengfelder;
    • Michael Unterhalt;
    • Wolfgang Hiddemann
    Publication type:
    Article
    46
    47
    48
    49
    50